eCARTv5 Clinical Deterioration Suite (eCART) vs Empatica Health Monitoring Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Empatica Health Monitoring Platform

by Empatica S.R.L.

AI Verdict

Tool A, AgileMD's eCARTv5, focuses on predicting clinical deterioration in hospitalized patients using EHR data to guide care pathways. Tool B, Empatica Health Monitoring Platform, utilizes wearable devices for continuous physiological monitoring and digital biomarker development, primarily for research and remote patient monitoring. While both offer FDA-cleared AI-powered solutions for health monitoring, their core methodologies and target applications differ significantly, making them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an AI-powered early warning system integrated with your EHR to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients. It's ideal for guiding care with embedded clinical pathways and minimizing false alarms to reduce clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Empatica Health Monitoring Platform if…

Choose Empatica Health Monitoring Platform if you require a full-stack digital health solution for continuous physiological monitoring and digital biomarker development, particularly for academic research or clinical trials. This platform is well-suited for remote data collection using medical-grade wearables and for studies in specialties like cardiology, neurology, and sleep medicine.

View Empatica Health Monitoring Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Empatica Health Monitoring Platform
Pricing	Contact vendor for tailored quote.	Contact for pricing
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based with companion mobile application and wearable devices.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

AgileMD's eCARTv5 integrates directly into existing EHR workflows, which can improve usability by minimizing disruption to clinical staff's routines. Empatica's platform, while requiring a wearable device and companion app, emphasizes an intuitive patient experience and streamlined data collection, suggesting a focus on user-friendliness for patients and researchers. Both tools aim to reduce burden, albeit for different user groups and through different mechanisms, making it a tie in overall usability without more specific comparative data.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 has demonstrated superior performance in predicting clinical deterioration (death or ICU transfer) in hospitalized adult patients, outperforming traditional scoring methods and Epic's Deterioration Index in extensive validation studies. Empatica's platform offers continuous physiological monitoring and digital biomarkers, which are valuable for research and specific conditions like epilepsy and Parkinson's, but eCARTv5's direct impact on preventing adverse events in a broad hospitalized population gives it an edge in immediate clinical value.

Pricing & Value

Empatica Health Monitoring Platform

Empatica provides some public pricing details for academic research bundles and its EpiMonitor device with monthly subscriptions, offering transparency and options for different user segments. AgileMD's pricing is only available upon contacting the vendor for a tailored quote, which offers less upfront transparency. While both require contacting for full enterprise pricing, Empatica's partial transparency and specific bundles provide more immediate value insight.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is designed for direct integration into EHR systems and is already deployed in over 250 U.S. hospitals, indicating strong enterprise readiness for hospital-wide implementation. Empatica's platform, while scalable for clinical trials and remote monitoring, relies on wearable devices and a mobile app, which might introduce additional logistical considerations for large-scale hospital-wide deployment compared to a purely software-based EHR integration.

Innovation

Empatica Health Monitoring Platform

Empatica's platform leverages medical-grade wearable devices for continuous physiological data collection and the development of over 300 research-grade and 6 FDA-cleared digital biomarkers, showcasing significant innovation in remote patient monitoring and digital health. AgileMD's eCARTv5 is innovative in its AI-powered predictive analytics and EHR integration for clinical deterioration, but Empatica's focus on novel data streams from wearables and biomarker development represents a broader scope of innovation in data acquisition and application.

Support & Docs

Empatica Health Monitoring Platform

Empatica offers a comprehensive support center with user manuals in multiple languages for its various products and platforms, including detailed guides for the Care App and EmbracePlus. They also provide webinars and resources for academic and clinical trial users. AgileMD's documentation and support details are not as readily available or detailed in the provided information, suggesting Empatica has a more robust and transparent support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Empatica Health Monitoring Platform
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Empatica Health Monitoring Platform
Company	AgileMD	Empatica S.R.L.
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Full-stack digital health solution with FDA-cleared wearables and AI-powered analytics for continuous physiological monitoring and digital biomarker development in research and clinical care.
Primary Categories	Clinical Decision Support & Reference, Triage & ER/ICU AI	Clinical Decision Support & Reference, Drug Discovery & Research, Wearables & Remote Monitoring (RPM)
Key Features (Selection)	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables)	Medical-grade wearable devices (EmbracePlus, EmbraceMini), Continuous physiological data collection (EDA, PPG, Accelerometer, Temperature, SpO2, Pulse Rate, Respiratory Rate), Clinically validated digital biomarkers (300+ research-grade, 6 FDA-cleared)

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Empatica Health Monitoring Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

eCARTv5 is designed for deep EHR integration, continuously assessing patient risk using up to 97 real-time variables from the EHR and embedding clinical pathways for care guidance. Empatica's platform, while cloud-based with a mobile app and wearables, offers an SDK to integrate medical-grade data from EmbracePlus into existing infrastructure and EHRs, allowing for remote patient monitoring and data visualization in a dedicated portal.

What is the accuracy and sensitivity of each tool in identifying relevant clinical events?

eCARTv5 has demonstrated high accuracy in predicting clinical deterioration (ICU transfer or death within 24 hours), with an AUROC of 0.834 in retrospective validation and maintaining high performance (AUROC u22650.80) across diverse patient demographics and clinical conditions in prospective validation. Empatica's platform focuses on continuous physiological data collection and clinically validated digital biomarkers, with over 300 research-grade and 6 FDA-cleared biomarkers, but specific accuracy metrics for predicting clinical deterioration are not provided in the given information.

Which clinical specialties are best served by each tool, and how adaptable are they to other areas?

eCARTv5 is specifically designed for critical care, emergency medicine, and hospital medicine, focusing on hospitalized adult patients at risk of clinical deterioration. Empatica's platform, with its wearable devices and continuous physiological monitoring, is suited for cardiology, neurology, and sleep medicine, and is scalable for clinical trials and academic research across various therapeutic areas.

What kind of learning curve can physicians expect when adopting these tools?

eCARTv5 integrates directly into the EHR and guides care with embedded clinical pathways, suggesting a potentially lower learning curve for physicians as it augments existing workflows. Empatica's platform involves wearable devices and a companion mobile application, which may require some initial patient and staff education for proper device use and data collection, though the Care Portal is designed for managing studies and accessing data.

What audit-trail features are available to track how the AI's recommendations influenced clinical decisions?

The provided information does not explicitly detail specific audit-trail features for either eCARTv5 or Empatica's platform. However, eCARTv5's integration with EHRs and its use of up to 97 real-time variables for risk assessment suggest that its recommendations would be part of the patient's electronic record. Empatica's platform offers raw data access and export, which could support auditing of collected physiological data.

How do these tools support multi-site rollouts and consistent implementation across different facilities?

eCARTv5 has been validated through extensive clinical performance data from nearly two million hospitalizations across 21 hospitals, indicating its capability for multi-site deployment and consistent accuracy across diverse patient demographics and medical conditions. Empatica's platform allows for easy setup of multiple sites from a single cloud-based portal and can monitor thousands of ambulatory patients simultaneously, suggesting strong support for multi-site rollouts.

Beyond HIPAA, what additional security measures are in place to protect patient data?

While both tools are HIPAA compliant, the provided information does not detail specific security measures beyond HIPAA for either eCARTv5 or Empatica's platform. Empatica does state that its cloud securely stores data.